振东制药
No insider purchase over the last 90 days. The latest was filed 26 Jan 2026.
Shanxi Zhendong Pharmaceutical Co.,Ltd is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). In the past year (18 October 2025 to 18 October 2026), 1 filing came from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €1,159, made by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €1,159, the purchase published on 26 January 2026 by 雷振宏 is the largest of the period. Those buying include 1 board member.
The latest purchase dates back some time: it was published 265 days ago, on 26 January 2026.
For context, the typical company on the same exchange (median of 533 companies) published 2 filings over the same period, against 1 filing here. Since 2021, the database holds 1 purchase and 1 sale by insiders of the company.
In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2024 · cache
振东制药 is a company focused on the manufacturing of pharmaceutical products. It is listed on the XSHE market.